Literature DB >> 11072198

Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers.

P Saha1, J H Kou.   

Abstract

The purpose of this study was to evaluate the effects of solubilizing excipients on Caco-2 transport parameters of poorly water-soluble NCEs (new chemical entities), and determine their permeability class under the BCS guidance (Biopharmaceutics Classification System). The effect of solubilizing excipients on soluble donor concentration of Sch 56592, Sch-X and Sch-Y was estimated. The transport of reference compounds and NCEs was studied across Caco-2 monolayers in absence or presence of solubilizing agents. The Caco-2 permeability of reference compounds showed good correlation with their extent of human oral absorption data. Sch 56592, Sch-X and Sch-Y exhibited high baseline Caco-2 permeability (>10(-5) cm/s). Povidone (1%) improved soluble donor concentration and flux of Sch 56592 by 40%. Other solubilizing excipients predominantly improved Sch 56592 soluble donor concentration, with either no change or a decrease in flux. With Sch-X, 1% povidone, pluronic F68, gelucir 44/14, and 3:2 propylene glycol/Tween-80 markedly improved soluble donor concentration, while increasing Sch-X flux by 40-65%. The soluble donor concentration of Sch-Y was also enhanced by excipients; however, only 1% pluronic F68 and PEG 300 increased Sch-Y flux by 35-50%. Sch 56592, Sch-X and Sch-Y are low solubility-high permeability compounds under the BCS guidance. For such poorly water-soluble NCEs, solubilizing excipients should be carefully screened based on their effects on solubility profiles and membrane transport.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072198     DOI: 10.1016/s0939-6411(00)00113-2

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  5 in total

1.  The effects of pluronics block copolymers and Cremophor EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells.

Authors:  Fergal Seeballuck; Marianne B Ashford; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

2.  Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations.

Authors:  Farkad Ezzet; David Wexler; Rachel Courtney; Gopal Krishna; Josephine Lim; Mark Laughlin
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  An Insight into Eudragit S100 Preserving Mechanism of Cinnarizine Supersaturation.

Authors:  Maryam Maghsoodi; Saeideh Mollaie Astemal; Ali Nokhodchi; Hossein Kiaie; Ali Baradar Khoshfetrat; Fatemeh Talebi
Journal:  AAPS PharmSciTech       Date:  2022-03-01       Impact factor: 3.246

4.  Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers.

Authors:  Gopal Krishna; Allen Moton; Lei Ma; Matthew M Medlock; James McLeod
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

5.  Method to screen substrates of apical sodium-dependent bile acid transporter.

Authors:  Rana Rais; Pablo M Gonzalez; Xiaowan Zheng; Stephen A Wring; James E Polli
Journal:  AAPS J       Date:  2008-12-16       Impact factor: 4.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.